AbbVie Inc (ABBV) — Cash Flow-to-Debt Ratio
AbbVie Inc (ABBV) has a Cash Flow-to-Debt Ratio of 0.04x as of December 2025, meaning its operating cash flow of $5.22 Billion could theoretically repay 0% of its total liabilities ($137.19 Billion) in one year. Explore AbbVie Inc (ABBV) long-term investment share to see how much of total assets are deployed in long-term investments.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
AbbVie Inc Cash Flow-to-Debt Ratio (2010–2025)
Historical debt coverage capacity for AbbVie Inc across 16 annual periods. Also explore ABBV total asset value for the complete picture of this company's asset base.
Annual Cash Flow-to-Debt Ratio for AbbVie Inc (2010–2025)
Year-by-year debt coverage analysis for AbbVie Inc. For market capitalisation and broader financial context, see AbbVie Inc (ABBV) market capitalisation.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.14x | $19.03 Billion | $137.19 Billion | ▼ -2.8% |
| 2024 | 0.14x | $18.81 Billion | $131.80 Billion | ▼ -22.3% |
| 2023 | 0.18x | $22.84 Billion | $124.31 Billion | ▼ -10.5% |
| 2022 | 0.21x | $24.94 Billion | $121.52 Billion | ▲ +18.1% |
| 2021 | 0.17x | $22.78 Billion | $131.09 Billion | ▲ +35.8% |
| 2020 | 0.13x | $17.59 Billion | $137.47 Billion | ▼ -6.6% |
| 2019 | 0.14x | $13.32 Billion | $97.29 Billion | ▼ -30.8% |
| 2018 | 0.20x | $13.43 Billion | $67.80 Billion | ▲ +30.6% |
| 2017 | 0.15x | $9.96 Billion | $65.69 Billion | ▲ +32.4% |
| 2016 | 0.11x | $7.04 Billion | $61.46 Billion | ▼ -25.3% |
| 2015 | 0.15x | $7.54 Billion | $49.10 Billion | ▲ +11.4% |
| 2014 | 0.14x | $3.55 Billion | $25.77 Billion | ▼ -45.7% |
| 2013 | 0.25x | $6.27 Billion | $24.71 Billion | ▼ -5.5% |
| 2012 | 0.27x | $6.34 Billion | $23.64 Billion | ▼ -67.4% |
| 2011 | 0.82x | $6.25 Billion | $7.59 Billion | ▼ -10.1% |
| 2010 | 0.92x | $4.98 Billion | $5.43 Billion | — |